KLK3 and Familial prostate cancer: Although a large part of this increase in prostate cancer survival in the general population has been due to the increase in the number of diagnoses of tumors with a very good prognosis caused by the widespread use of the prostate-specific antigen (PSA) test, both studies concluded that the information about stage only is not enough to explain the differences in survival observed among countries.